| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/26/1995 | EP0663953A1 Phagemids coexpressing a surface receptor and a surface heterologous protein |
| 07/26/1995 | EP0663952A1 Transgenic non-human animals having targeted lymphocyte transduction genes |
| 07/26/1995 | EP0663925A1 Affinity purification methods involving amino acid mimetics as elution reagents |
| 07/26/1995 | EP0663921A1 Method for increasing expression and reducing expression variability of foreign genes in plant cells |
| 07/26/1995 | EP0663837A1 Prevention of suppression of immune defense against cancer caused by the cancer-associated scm-recognition peptide |
| 07/26/1995 | EP0663834A1 Growth hormone releasing peptides |
| 07/26/1995 | EP0643584A4 Delivery of a cytotoxic compound to a cancer cell using a pathway of plasminogen activator material. |
| 07/26/1995 | EP0596929B1 Amide derivatives of antibiotic a 40926 |
| 07/26/1995 | EP0522036B1 BACILLUS THURINGIENSIS cryIIIC GENE AND PROTEIN TOXIC TO COLEOPTERAN INSECTS. |
| 07/26/1995 | EP0416037B1 Superoxide dismutase analogs having novel binding properties |
| 07/26/1995 | EP0167616B1 Cytokeratin tumor markers and assays for their detection |
| 07/26/1995 | CN1105800A Selective crosslinking of hemoglobins by oxidized, ring-opened saccharides |
| 07/26/1995 | CN1105704A Oilseed crops producing valuable seeds having altered amino acid composition and fatty acid composition |
| 07/26/1995 | CN1105670A Human embryo collagen and preparing method thereof |
| 07/26/1995 | CA2140988A1 Saccharomyces-specific antigens and antibodies, their preparation and use |
| 07/25/1995 | US5436394 Plasmid for the preparation of transgenic plants with a change in habit and yield |
| 07/25/1995 | US5436393 Potato tuber specific transcriptional regulation |
| 07/25/1995 | US5436392 Manduca insect enzyme inhibitor for plants such as cotton, alfalfa and tobaccoew to prevent damage |
| 07/25/1995 | US5436391 Genetically engineered plant of genus oryza produced by transforming the specific vector into protoplasts derived from above plant, growing said protoplast to form colonies an regenerating plants form the colonies |
| 07/25/1995 | US5436321 Antibodies to the lipopolysaccharide bonding opsonin septin |
| 07/25/1995 | US5436320 Antibody reagents that identify the carboxy-terminal peptide of the GTP-binding protein Go |
| 07/25/1995 | US5436319 Lymphocytes for immunoassay |
| 07/25/1995 | US5436318 Hepatitis C virus epitopes |
| 07/25/1995 | US5436228 Chemotactic wound healing peptides |
| 07/25/1995 | US5436221 Oligopeptides as antitumor agents |
| 07/25/1995 | US5436170 Crosslinking |
| 07/25/1995 | US5436169 Protein associated with acute pancreatitis agents for the screening of acute pancreatitis |
| 07/25/1995 | US5436163 Kit for typing platelet alloantigens comprising means for amplifying gene, receptacle containing labeled oligonucleotide probe or restriction endonuclease to distinguish sequences |
| 07/25/1995 | US5436162 Human manganese superoxide dismutase (hMn-SOD) |
| 07/25/1995 | US5436157 Human intra-acrosomal sperm antigen |
| 07/25/1995 | US5436155 Isolated DNA encoding a somatostatin receptor |
| 07/25/1995 | US5436154 Stable hybridoma cells and antigen-antibodies |
| 07/25/1995 | US5436153 Human amyloid protein precursor homolog and Kunitz-type inhibitor |
| 07/25/1995 | US5436139 Non-passageable virus |
| 07/25/1995 | US5436137 Promoting fertilization |
| 07/25/1995 | US5436136 Repressible yeast promoters |
| 07/25/1995 | US5436128 Assay methods and compositions for detecting and evaluating the intracellular transduction of an extracellular signal |
| 07/25/1995 | US5436127 Epitope-related peptides of human parvovirus |
| 07/25/1995 | US5436126 Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines |
| 07/25/1995 | US5436002 Bacillus thuringiensisisolate PS201T6 toxin |
| 07/25/1995 | US5436000 Flagella-less borrelia |
| 07/25/1995 | CA2140834A1 Method for removing the prions in collagens and collagens thereby obtained |
| 07/25/1995 | CA1336473C Synthetic peptide antigens for the detection of hiv-1 infection |
| 07/25/1995 | CA1336416C Production of human serum albumin by fermentation |
| 07/25/1995 | CA1336407C Prevention and treatment of retroviral disease |
| 07/25/1995 | CA1336404C General cancer-associated scm-recognition factor, preparation and method of use |
| 07/25/1995 | CA1336403C Human relaxin formulation |
| 07/25/1995 | CA1336399C Adjuvant for cancer immunotherapy |
| 07/25/1995 | CA1336398C Method for reducing side effects of cancer therapy |
| 07/21/1995 | CA2140591A1 Antigen-specific, activated t lymphocytes, detection and use |
| 07/20/1995 | WO1995019568A1 Hydrophilic signal oligopeptides and methods of therapeutic use |
| 07/20/1995 | WO1995019448A1 Nucleic acid mutation detection in histologic tissue |
| 07/20/1995 | WO1995019443A2 Chemically regulatable and anti-pathogenic dna sequences and uses thereof |
| 07/20/1995 | WO1995019438A1 Equine arteritis virus peptides, antibodies and their use in a diagnostic test |
| 07/20/1995 | WO1995019437A1 Cross-reactive allergen |
| 07/20/1995 | WO1995019436A1 Mammalian monocyte chemoattractant protein receptors |
| 07/20/1995 | WO1995019435A2 T cell antigen receptor v region proteins and methods of preparation thereof |
| 07/20/1995 | WO1995019434A1 Tissue-specific enhancer active in prostate |
| 07/20/1995 | WO1995019432A1 Cell lines, maturation factors and use of said cell lines and factors |
| 07/20/1995 | WO1995019431A1 Zinc finger protein derivatives and methods therefor |
| 07/20/1995 | WO1995019429A2 Method and reagent for inhibiting hepatitis c virus replication |
| 07/20/1995 | WO1995019428A1 Retroviral vector particles for transducing non-proliferating cells |
| 07/20/1995 | WO1995019426A1 Method of targeting dna insertion into genome |
| 07/20/1995 | WO1995019375A1 Peptides and methods against psoriasis |
| 07/20/1995 | WO1995019374A1 Bacterial receptor structures |
| 07/20/1995 | WO1995019372A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 07/20/1995 | WO1995019371A2 Expression of surface layer proteins |
| 07/20/1995 | WO1995019370A1 Ion-channel forming amphiphilic peptides having n-terminal modifications |
| 07/20/1995 | WO1995019369A1 Method for detection and treatment of breast cancer |
| 07/20/1995 | WO1995019367A1 Screening assays for identifying agents that affect p53-dependent expression |
| 07/20/1995 | WO1995019187A1 Biological targeting agents |
| 07/20/1995 | WO1995019183A1 Cd44 expression in smooth muscle cells |
| 07/20/1995 | WO1995019182A1 Somatic gene therapy to cells associated with fluid spaces |
| 07/20/1995 | WO1995019181A1 A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS |
| 07/20/1995 | WO1995019180A1 Anti-gram-positive bacterial methods and materials |
| 07/20/1995 | WO1995019179A1 Anti-fungal methods and materials |
| 07/20/1995 | WO1995019167A1 Therapeutic treatment for inhibiting vascular restenosis |
| 07/20/1995 | WO1995011300A3 Azoospermia identification and treatment |
| 07/20/1995 | WO1995007995A3 Adeno-associated viral (aav) liposomes and methods related thereto |
| 07/20/1995 | DE4400745A1 Screening test for inhibitors of beta=fibrinogen expression |
| 07/20/1995 | DE19500723A1 New variable domains of antibody recognising cancer specific mucin |
| 07/20/1995 | CA2210396A1 Method for detection and treatment of breast cancer |
| 07/20/1995 | CA2181347A1 Cell lines, maturation factors and use of said cell lines and factors |
| 07/20/1995 | CA2181171A1 T cell antigen receptor v region proteins and methods of preparation thereof |
| 07/20/1995 | CA2181170A1 Somatic gene therapy to cells associated with fluid spaces |
| 07/20/1995 | CA2181159A1 Equine arteritis virus peptides, antibodies and their use in a diagnostic test |
| 07/20/1995 | CA2181147A1 Nucleic acid mutation detection in histologic tissue |
| 07/20/1995 | CA2181142A1 Cross-reactive allergen |
| 07/20/1995 | CA2181035A1 Therapeutic treatment for inhibiting vascular restenosis |
| 07/20/1995 | CA2180748A1 Ion-channel forming amphiphilic peptides having n-terminal modifications |
| 07/20/1995 | CA2180740A1 Method and reagent for inhibiting hepatitis c virus replication |
| 07/20/1995 | CA2179990A1 Biological targeting agents |
| 07/20/1995 | CA2179391A1 Cd44 expression in smooth muscle cells |
| 07/20/1995 | CA2179280A1 Peptides and methods against psoriasis |
| 07/19/1995 | EP0663444A1 Cell lines, maturation factors and use of said cell lines and factors |
| 07/19/1995 | EP0663407A1 Process for preparation of reconstituted lipoproteins |
| 07/19/1995 | EP0663406A1 VIP analog |
| 07/19/1995 | EP0663404A1 Antibodies for the detection of Salmonella |
| 07/19/1995 | EP0663403A1 Vector vaccines of bovine herpesvirus I |
| 07/19/1995 | EP0663014A1 Dna encoding human alpha 1 adrenergic receptors and uses thereof |